Literature DB >> 30785102

Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.

A Prieto-García1, B Noguerado1, P Rojas1, I Torrado1, A Rodríguez-Fernández1, P Tornero1.   

Abstract

Entities:  

Keywords:  Anaphylaxis; Drug allergy; Drug desensitization; Omalizumab; Oxaliplatin

Mesh：

Substances：

Year:  2019        PMID： 30785102     DOI： 10.18176/jiaci.0326

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  3 in total

Review 1.  Drug Desensitizations for Chemotherapy: Safety and Efficacy in Preventing Anaphylaxis.

Authors:  Joana Caiado; Mariana C Castells
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-07       Impact factor: 4.806

2.  Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study.

Authors:  Hanneke N G Oude Elberink; Mathilde Jalving; Hilda Dijkstra; Annick A J M van de Ven
Journal:  Clin Transl Allergy       Date:  2020-01-29       Impact factor: 5.871

Review 3.  Omalizumab for successful chemotherapy desensitisation: What we know so far.

Authors:  Roxana Silvia Bumbacea; Selda Ali; Sabina Loredana Corcea; Luiza Spiru; Cornelia Nitipir; Victor Strambu; Dragos Bumbacea
Journal:  Clin Transl Allergy       Date:  2021-12-13       Impact factor: 5.871
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.